Screening compound: C17H21ClN4O2 (T815-0937)

Screening compound: C<sub>17</sub>H<sub>21</sub>ClN<sub>4</sub>O<sub>2</sub> (T815-0937)
Screening compound: C<sub>17</sub>H<sub>21</sub>ClN<sub>4</sub>O<sub>2</sub> (T815-0937) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C17H21ClN4O2 (T815-0937)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T815-0937

Molecular Formula

C17H21ClN4O2 (C17 H21 ClN4 O2)

Compound Name

2-(4-CHLOROPHENOXY)-1-[3-(PROPAN-2-YL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]PROPAN-1-ONE

IUPAC name

2-(4-chlorophenoxy)-1-[3-(propan-2-yl)-5H6H7H8H-[124]triazolo[43-a]pyrazin-7-yl]propan-1-one

SMILES

CC(C)c1nnc(C2)n1CCN2C(C(C)Oc(cc1)ccc1Cl)=O

InChI

InChI=1S/C17H21ClN4O2/c1-11(2)16-20-19-15-10-21(8-9-22(15)16)17(23)12(3)24-14-6-4-13(18)5-7-14/h4-7,11-12H,8-10H2,1-3H3/t12-/m0/s1

InChI Key

VXRALORSZOWKIU-LBPRGKRZSA-N

MDL Number (MFCD)

MFCD29027673

C17H21ClN4O2 (T815-0937) in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-infective Library (19449 compounds)

Anti-Inflammatory Library (24602 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

SmartTM Library (51161 compounds)

TLR-8 ligands Library (674 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Female
  • Skin
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • Epigenetic
Targets:
  • Others
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C17H21ClN4O2 (T815-0937) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C17H21ClN4O2 (T815-0937)?
Check Price and Availability of C17H21ClN4O2 (T815-0937), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C17H21ClN4O2 (T815-0937) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C17H21ClN4O2 (T815-0937)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C17H21ClN4O2 (T815-0937)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C17H21ClN4O2 (T815-0937) available by request